Metraipolis › archive › dc_452e02aa9bdb
Preclinical biodistribution and toxicology assessment of an AAV5-based subretinal modifier gene therapy for retinitis pigmentosa — Europe PMC PMID:41234928
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41234928
- DOI
- 10.3389/fmed.2025.1679619
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T23:12:26.164Z
- SHA-256 of the archived text
222ad3ee66773d49596f1a220c7a1d8b31d42cdddc6afe71adc283a8acda8713- Stable URL of this page
https://metraipolis.com/documento/dc_452e02aa9bdb
How to cite
Preclinical biodistribution and toxicology assessment of an AAV5-based subretinal modifier gene therapy for retinitis pigmentosa — Europe PMC PMID:41234928 — Europe PMC (en), https://europepmc.org/article/MED/41234928 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_452e02aa9bdb (Metraipolis archive dc_452e02aa9bdb, sha256 222ad3ee66773d49596f1a220c7a1d8b31d42cdddc6afe71adc283a8acda8713)
BibTeX
@misc{dc452e02aa9bdb,
title = {Preclinical biodistribution and toxicology assessment of an AAV5-based subretinal modifier gene therapy for retinitis pigmentosa — Europe PMC PMID:41234928},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41234928},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_452e02aa9bdb; sha256 222ad3ee66773d49596f1a220c7a1d8b31d42cdddc6afe71adc283a8acda8713},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41234928. Agents can read the archived copy with the MCP tool read_document.